GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xeris Biopharma Holdings XERS · USD

Health Care · US listing · 🇺🇸 United States

Compare

15.86

+4.34%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Xeris Biopharma Holdings and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Xeris Biopharma Holdings XERS 15.86$2.74bn3261.50.2%— +4.34%
Astrana Health ASTH 33.77$1.69bn82.70.7%— -2.12%
Phathom Pharmaceuticals PHAT 5.33$415.3m—-126.3%— +1.52%
BioLife Solutions BLFS ———-12.6%— —
Uniqure QURE 22.79$1.31bn—-1236.0%— +5.02%
Abcellera Biologics ABCL 12.50$3.74bn—-194.9%— +5.22%
Palvella Therapeutics PVLA 174.08$2.06bn—-128.5%— -1.05%
Evotec SE ADR EVO 1.74$618.0m—-13.1%— +2.96%
Pacira Biosciences PCRX 36.46$1.64bn233.11.0%— +0.08%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.